Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Reproductive Biology and Endocrinology
Published in: Reproductive Biology and Endocrinology 1/2016

Open Access 01-12-2016 | Research

Analysis of 17β-estradiol (E2) role in the regulation of corpus luteum function in pregnant rats: Involvement of IGFBP5 in the E2-mediated actions

Authors: Sudeshna Tripathy, Killivalavan Asaithambi, Jayaram P, Medhamurthy R

Published in: Reproductive Biology and Endocrinology | Issue 1/2016

Login to get access

Abstract

Background

In several species, considerably higher levels of estradiol-17 (E2) are synthesized in the CL. E2 has been suggested to participate in the regulation of luteal steroidogenesis and luteal cell morphology. In pregnant rats, several experiments have been carried out to examine the effects of inhibition of luteal E2 synthesis on CL structure and function.

Methods

During days 12–15 of pregnancy in rats, luteal E2 was inhibited by way of daily oral administration of anastrozole (AI), a selective non-steroidal aromatase inhibitor, and experiments were also performed with E2 replacement i.e. AI+ E2 treatments. Luteal tissues from different treatment groups were subjected to microarray analysis and the differentially expressed genes in E2 treated group were further examined for expression of specific E2 responsive genes. Additional experiments were carried out employing recombinant growth hormone preparation and flutamide, an androgen receptor antagonist, to further address the specificity of E2 effects on the luteal tissue.

Results

Microarray analysis of CL collected on day 16 of pregnancy post AI and AI+E2 treatments showed significantly lowered cyp19a1 expression, E2 levels and differential expression of a number of genes, and several of them were reversed in E2 replacement studies. From the differentially expressed genes, a number of E2 responsive genes were identified. In CL of AI pregnant rats, non-significant increase in expression of igf1, significant increase in igbp5, igf1r and decrease in expression of Erα were observed. In liver of AI treated rats, igf1 expression did not increase, but GH treatment significantly increased expression that was further increased with AI treatment. In CL of GH and AI+GH treated rats, expression of igfbp5 was higher. Administration of flutamide during days 12–15 of pregnancy resulted in non-significant increase in igfbp5 expression, however, combination of flutamide+AI treatments caused increased protein expression. Expression of few of the molecules in PI3K/Akt kinase pathway in different treatments was determined.

Conclusions

The results suggest a role for E2 in the regulation of luteal steroidogenesis, morphology and proliferation. igfbp5 was identified as one the E2 responsive genes with important role in the mediation of E2 actions such as E2-induced phosphorylation of PI3K/Akt kinase pathway.
Appendix
Available only for authorised users
Literature
1.
Arioua RK, Féral C, Benhaïm A, Delarue B, Leymarie P. Luteotrophic factors in hyperstimulated pseudopregnant rabbit: I--evidence for aromatase activity in luteal tissue and luteal cells. J Endocrinol. 1997;154:249–57. doi:10.​1677/​joe.​0.​1540259.CrossRefPubMed
2.
3.
4.
Carlsson B, Nilsson A, Isaksson OGP, Billig H. Growth hormone-receptor messenger RNA in the rat ovary: regulation and localization. Mol Cell Endocrinol. 1993;95:59–66.CrossRefPubMed
5.
Duan C, Clemmons DR. Differential expression and biological effects of insulin-like growth factor-binding protein −4 and −5 in vascular smooth muscle cells. J Biol Chem. 1998;273:16836–42.CrossRefPubMed
6.
Erickson GF, Nakatani A, Ling N, Shimasaki S. Localization of insulin-like growth factor-binding protein-5 messenger ribonucleic acid in rat ovaries during the estrous cycle. Endocrinology. 1992;130:1867–78.PubMed
7.
Gadsby JE, Lovdal JA, Samaras S, Barber JS, Hammond JM. Expression of the messenger ribonucleic acids for insulin-like growth factor-I and insulin-like growth factor binding proteins in porcine corpora lutea. Biol Reprod. 1996;54:339–46.CrossRefPubMed
8.
Garcia-Reyero N, Ekman DR, Habib T, Villeneuve DL, Collette TW, Bencic DC, Ankley GT & Perkins E. Integrated approach to explore the mechanisms of aromatase inhibition and recovery in fathead minnows (Pimephales promelas). Gen Comp Endocrinol. 2014;203:193–202.CrossRefPubMed
9.
Gibori G, Sridaran R. Sites of androgen and estradiol production in the second half of pregnancy in the rat. Biol Reprod. 1981;24:249–56.CrossRefPubMed
10.
Gibori G, Antczak E, Rothchild I. The role of estrogen in the regulation of luteal progesterone secretion in the rat after day 12 of pregnancy. Endocrinology. 1977;100:1483–95.CrossRefPubMed
11.
Gibori G, Chen Y-DI, Khan I, Azhar S, Reaven GM. Regulation of luteal cell lipoprotein receptors, sterol content and steroidogenesis by estradiol in the pregnant rat. Endocrinology. 1984;114:609–17.CrossRefPubMed
12.
Gibori G, Khan I, Warshaw ML, McLean MP, Puryear TK, Nelson S, Durkee TJ, Azhar S, Steinschneider A & Rao MC. Placental-derived regulators and the complex control of luteal cell function. Recent Prog Horm Res. 1988;44:377–429. doi:10.​1016/​B978-0-12-571144-9.​50016-8.PubMed
13.
14.
González-Fernández R, Martínez-Galisteo E, Gaytán F, Bárcena JA, Sánchez-Criado JE. Changes in the proteome of functional and regressing corpus luteum during pregnancy and lactation in the rat. Biol Reprod. 2008;79:100–14.CrossRefPubMed
15.
Goodman SB, Kugu K, Chen SH, Preutthipan S, Tilly KI, Tilly JL & Dharmarajan AM. Estradiol-mediated suppression of apoptosis in the rabbit corpus luteum is associated with a shift in expression of bcl-2 family members favoring cellular survival. Biol Reprod. 1998;59:820–7. doi:10.​1095/​biolreprod59.​4.​820.CrossRefPubMed
16.
17.
Grisouard J, Medunjanin S, Hermani A, Shukla A, Mayer D. Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor. Mol Endocrinol. 2007;21:2427–39. doi:10.​1210/​me.​2007-0129.CrossRefPubMed
18.
Hermani A, Shukla A, Medunjanin S, Werner H, Mayer D. Insulin-like growth factor binding protein-4 and −5 modulate ligand-dependent estrogen receptor-activation in breast cancer cells in an IGF-independent manner. Cell Signal. 2013;25:1395–402.CrossRefPubMed
19.
20.
Juengel JL, Meberg BM, Turzillo AM, Nett TM, Niswender GD. Hormonal regulation of messenger ribonucleic acid encoding steroidogenic acute regulatory protein in ovine corpora lutea. Endocrinology. 1995;136:5423–9.PubMed
21.
22.
Kenny N, Farin CE, Niswender GD. Morphometric quantification of mitochondria in the two steroidogenic ovine luteal cell types. Biol Reprod. 1989;40:191–6.CrossRefPubMed
23.
24.
Kunal SB, Killivalavan A, Medhamurthy R. Involvement of Src family of kinases and cAMP phosphodiesterase in the luteinizing hormone/chorionic gonadotropin receptor-mediated signaling in the corpus luteum of monkey. Reprod Biol Endocrinol. 2012;10:25. doi:10.​1186/​1477-7827-10-25.CrossRefPubMedPubMedCentral
25.
Liu ZL, Palmquist DE, Ma M, Liu J, Alexander NJ. Application of a master equation for quantitative mRNA analysis using qRT-PCR. J Biotechnol. 2009;143:10–6.CrossRefPubMed
26.
Martin MB, Stoica A. Insulin-like growth factor-I and estrogen interactions in breast cancer. J Nutr. 2002;132:3799S–801S.PubMed
27.
Medunjanin S, Hermani A, De Servi B, Grisouard J, Rincke G, Mayer D. Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor alpha and is involved in the regulation of receptor activity. J Biol Chem. 2005;280:33006–14. doi:10.​1074/​jbc.​M506758200.CrossRefPubMed
28.
Niswender GD, Juengel JL, Silva PJ, Rollyson MK, McIntush EW. Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev. 2000;80:1–29.PubMed
29.
Priyanka S, Jayaram P, Sridaran R, Medhamurthy R. Genome-wide gene expression analysis reveals a dynamic interplay between luteotropic and luteolytic factors in the regulation of corpus luteum function in the bonnet monkey (Macaca radiata). Endocrinology. 2009;150:1473–84. doi:10.​1210/​en.​2008-0840.CrossRefPubMedPubMedCentral
30.
Rosenfeld CS, Wagner JS, Roberts RM, Lubahn DB. Intraovarian actions of oestrogen. Reproduction. 2001;122:215–26.CrossRefPubMed
31.
Royer C, Lucas TF, Lazari MF, Porto CS. 17Beta-estradiol signaling and regulation of proliferation and apoptosis of rat Sertoli cells. Biol Reprod. 2012;86:108.CrossRefPubMed
32.
33.
Shibaya M, Matsuda A, Hojo T, Acosta TJ, Okuda K. Expressions of estrogen receptors in the bovine corpus luteum: cyclic changes and effects of prostaglandin F2alpha and cytokines. J Reprod Dev. 2007;53:1059–68. doi:10.​1262/​jrd.​19065.CrossRefPubMed
34.
Słomczyńska M, Duda M, Galas J. Estrogen receptor alpha and beta expression in the porcine ovary. Folia Histochem Cytobiol. 2001;39:137–8.PubMed
35.
36.
Stocco C, Telleria C, Gibori G. The molecular control of corpus luteum formation, function, and regression. Endocr Rev. 2007;28:117–49.CrossRefPubMed
37.
38.
Tao Y, Song X, Deng X, Xie D, Lee LM, Liu Y, Li W, Li L, Deng L, Wu Q, et al. Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1. Exp Cell Res. 2005;303:240–51. doi:10.​1016/​j.​yexcr.​2004.​09.​030.CrossRefPubMed
39.
Varco-Merth B, Rotwein P. Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression. Am J Physiol Endocrinol Metab. 2014;307:E847–55.CrossRefPubMedPubMedCentral
40.
41.
Westley BR, May FE. Role of insulin-like growth factors in steroid modulated proliferation. J Steroid Biochem Mol Biol. 1994;51:1–9.CrossRefPubMed
42.
Waters MJ, Hoang HN, Fairlie DP, Pelekanos RA, Brown RJ. New insights into growth hormone action. J Mol Endocrinol. 2006;36:1–7.CrossRefPubMed
43.
Yadav VK, Sudhagar RR, Medhamurthy R. Apoptosis during spontaneous and prostaglandin F(2alpha)-induced luteal regression in the buffalo cow (Bubalus bubalis): involvement of mitogen-activated protein kinases. Biol Reprod. 2002;67:752–9. doi:10.​1095/​biolreprod.​102.​004077.CrossRefPubMed
44.
Yee D, Lee AV. Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mammary Gland Biol Neoplasia. 2000;5:107–15.CrossRefPubMed
Metadata
Title
Analysis of 17β-estradiol (E2) role in the regulation of corpus luteum function in pregnant rats: Involvement of IGFBP5 in the E2-mediated actions
Authors
Sudeshna Tripathy
Killivalavan Asaithambi
Jayaram P
Medhamurthy R
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2016
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/s12958-016-0153-1

Other articles of this Issue 1/2016

Reproductive Biology and Endocrinology 1/2016 Go to the issue

Research

Flutamide induces alterations in the cell-cell junction ultrastructure and reduces the expression of Cx43 at the blood-testis barrier with no disturbance in the rat seminiferous tubule morphology

Research

ACTH-induced stress in weaned sows impairs LH receptor expression and steroidogenesis capacity in the ovary

Research

The importance of adrenal hypoandrogenism in infertile women with low functional ovarian reserve: a case study of associated adrenal insufficiency

Review

Risks of spontaneously and IVF-conceived singleton and twin pregnancies differ, requiring reassessment of statistical premises favoring elective single embryo transfer (eSET)

Research

Effect of nerve growth factor on sperm quality in asthenozoosprmic men during cryopreservation

Research

Reduced expressions of connexin 43 and VEGF in the first-trimester tissues from women with recurrent pregnancy loss